Peringkat dalam Saham
#35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Harga Saham
$0.14942078
Terakhir disinkronkan: 2025-05-15
Kapitalisasi Pasar
$3.86M
Perubahan (1 tahun)
0.00%
Perdagangan Medigene AG (MDG1)
Harga MDG1 dengan kapitalisasi pasar B
Kapitalisasi pasar dari Medigene AG(MDG1)
Kapitalisasi Pasar: $3.86M
Per August 2026, Medigene AG memiliki kapitalisasi pasar sebesar $3.86M. Ini menjadikan Medigene AG sebagai perusahaan 35468th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Medigene AG dari 2000 hingga 2026
MDG1 dibandingkan dengan 5 teratas stocks paling populer
| Harga MDG1 |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.452T
|
+141,055,068.21%
|
|
|
|
|
$4.490T
|
+116,169,363.61%
|
|
|
|
|
$4.162T
|
+107,693,088.99%
|
|
|
|
|
$3.676T
|
+95,117,229.79%
|
|
|
|
|
$2.833T
|
+73,298,689.27%
|
